JNJ (STOCKS)
Johnson & Johnson
$262.080000
+1.220000 (+0.47%)
Prev close: $260.860000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Joaquin Duato
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $647,697.51M
- Employees
- 139,800
- P/E (TTM)
- 30.23
- P/B (TTM)
- 7.39
- Dividend Yield
- 200.87%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $97.93B |
| Benefits Costs and Expenses | $72.73B |
| Cost Of Revenue | $31.43B |
| Costs And Expenses | $72.73B |
| Gross Profit | $66.50B |
| Operating Expenses | $41.31B |
| Selling, General, and Administrative Expenses | $25.14B |
| Other Operating Expenses | $16.06B |
| Operating Income/Loss | $25.20B |
| Income/Loss From Continuing Operations After Tax | $21.04B |
| Income/Loss From Continuing Operations Before Tax | $25.20B |
| Income Tax Expense/Benefit | $4.16B |
| Income Tax Expense/Benefit, Deferred | -$1.78B |
| Net Income/Loss | $21.04B |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $21.04B |
| Net Income/Loss Available To Common Stockholders, Basic | $21.04B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $8.73 |
| Diluted Earnings Per Share | $8.62 |
| Basic Average Shares | 4,816,500,000 |
| Diluted Average Shares | 4,877,100,000 |
| Common Stock Dividends | $5.24 |
| Assets | $201.06B |
| Current Assets | $59.77B |
| Cash | $20.76B |
| Inventory | $15.14B |
| Other Current Assets | $23.87B |
| Noncurrent Assets | $141.29B |
| Fixed Assets | $23.58B |
| Intangible Assets | $48.23B |
| Other Non-current Assets | $69.48B |
| Liabilities | $116.09B |
| Current Liabilities | $54.90B |
| Accounts Payable | $9.22B |
| Wages | $3.48B |
| Other Current Liabilities | $42.20B |
| Noncurrent Liabilities | $61.20B |
| Equity | $84.97B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $84.97B |
| Liabilities And Equity | $201.06B |
| Net Cash Flow From Operating Activities | $27.61B |
| Net Cash Flow From Operating Activities, Continuing | $27.61B |
| Net Cash Flow From Investing Activities | -$7.18B |
| Net Cash Flow From Investing Activities, Continuing | -$7.18B |
| Net Cash Flow From Financing Activities | -$18.54B |
| Net Cash Flow From Financing Activities, Continuing | -$18.54B |
| Exchange Gains/Losses | -$43.00M |
| Net Cash Flow | $1.85B |
| Net Cash Flow, Continuing | $1.89B |
| Comprehensive Income/Loss | $21.39B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $21.39B |
| Other Comprehensive Income/Loss | $354.00M |